Skip to content
10-K

Annual Report

EIGER BIOPHARMACEUTICALS, INC.

0001628280-24-015297

← back to feed
Filed
Apr 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 4, 2024 1.48M sh
Shares Diluted FY 2023 · Dec 31, 2023 1.48M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 1.39M sh
Capex FY 2023 · Dec 31, 2023 $234K
Capex FY 2023 · Dec 31, 2022 $340K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$74.55M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$83.01M
Long Term Debt FY 2023 · Dec 31, 2023 $0
Long Term Debt FY 2023 · Dec 31, 2022 $39.63M
Short Term Debt FY 2023 · Dec 31, 2023 $41.12M
Short Term Debt FY 2023 · Dec 31, 2022 $0
Cash And Equivalents FY 2023 · Dec 31, 2023 $25.44M
Cash And Equivalents FY 2023 · Dec 31, 2022 $25.8M
Stockholders Equity FY 2023 · Dec 31, 2023 −$14.46M
Stockholders Equity FY 2023 · Dec 31, 2022 $55.31M
Stockholders Equity FY 2023 · Dec 31, 2021 $72.4M
Current Liabilities FY 2023 · Dec 31, 2023 $53.28M
Current Liabilities FY 2023 · Dec 31, 2022 $25.12M
Total Liabilities FY 2023 · Dec 31, 2023 $53.28M
Total Liabilities FY 2023 · Dec 31, 2022 $64.83M
Current Assets FY 2023 · Dec 31, 2023 $37.84M
Current Assets FY 2023 · Dec 31, 2022 $117.54M
Total Assets FY 2023 · Dec 31, 2023 $38.83M
Total Assets FY 2023 · Dec 31, 2022 $120.14M
Eps Diluted FY 2023 · Dec 31, 2023 −$50.78
Eps Diluted restated FY 2023 · Dec 31, 2022 −$69.74
Eps Basic FY 2023 · Dec 31, 2023 −$50.78
Eps Basic restated FY 2023 · Dec 31, 2022 −$69.74
Sga Expense FY 2023 · Dec 31, 2023 $25.2M
Sga Expense FY 2023 · Dec 31, 2022 $29.11M
Rd Expense FY 2023 · Dec 31, 2023 $62.33M
Rd Expense FY 2023 · Dec 31, 2022 $75.28M
Net Income FY 2023 · Dec 31, 2023 −$74.96M
Net Income FY 2023 · Dec 31, 2022 −$96.78M
Operating Income FY 2023 · Dec 31, 2023 −$71.79M
Operating Income FY 2023 · Dec 31, 2022 −$92.74M
Cost Of Revenue FY 2023 · Dec 31, 2023 $24K
Cost Of Revenue FY 2023 · Dec 31, 2022 $1.84M
Revenue FY 2023 · Dec 31, 2023 $15.77M
Revenue FY 2023 · Dec 31, 2022 $13.48M